https://fortune.com/well/2022/09/24/new-covid-omicron-variants-subvariants-evade-monoclonal-antibodies-bebtelovimab-recombinants-convergent-evolution-sars-immune-evasion/
0
0
45 words
0
Comments
One up and coming variant renders society’s last universal COVID antibody drug powerless, experts say. Another variant isn’t far behind it.
You are the first to view
Create an account or login to join the discussion